Effectiveness of a fourth dose of mRNA COVID-19 vaccine against all-cause mortality in long-term care facility residents and in the oldest old: A nationwide …
P Nordström, M Ballin, A Nordström - The Lancet Regional Health …, 2022 - thelancet.com
Background The effect of a fourth dose of COVID-19 vaccine on the risk of death in the
oldest and frailest individuals is unknown. Methods Two matched cohorts were formed using …
oldest and frailest individuals is unknown. Methods Two matched cohorts were formed using …
mRNA vaccine effectiveness against COVID-19-related hospitalisations and deaths in older adults: a cohort study based on data linkage of national health registries in …
B Nunes, AP Rodrigues, I Kislaya, C Cruz… - …, 2021 - eurosurveillance.org
Through deterministic data linkage of health registries, mRNA vaccine effectiveness (VE)
against COVID-19-related hospitalisations and deaths was measured in 1,880,351 older …
against COVID-19-related hospitalisations and deaths was measured in 1,880,351 older …
[HTML][HTML] COVID-19 mRNA vaccine effectiveness (second and first booster dose) against hospitalisation and death during Omicron BA. 5 circulation: cohort study based …
I Kislaya, A Machado, S Magalhães… - …, 2022 - eurosurveillance.org
We measured vaccine effectiveness (VE) against COVID-19-related severe outcomes in
elderly people in Portugal between May and July 2022. In≥ 80 year-olds, the second …
elderly people in Portugal between May and July 2022. In≥ 80 year-olds, the second …
Effectiveness of Covid-19 vaccination against risk of symptomatic infection, hospitalization, and death up to 9 months: a Swedish total-population cohort study
P Nordström, M Ballin, A Nordström - Hospitalization, and Death …, 2021 - papers.ssrn.com
Background: Whether vaccine effectiveness against Coronavirus disease 2019 (Covid-19)
lasts longer than 6 months is unclear. Methods: A retrospective cohort study was conducted …
lasts longer than 6 months is unclear. Methods: A retrospective cohort study was conducted …
Reduced risk of severe COVID-19 in more than 1.4 million elderly people aged 75 years and older vaccinated with mRNA-based vaccines
J Botton, R Dray-Spira, B Baricault, J Drouin… - Vaccine, 2022 - Elsevier
Randomized clinical trials have shown mRNA-based vaccines to be 92–95% effective to
prevent COVID-19 in adults. We aimed to estimate the impact of vaccination on the risk of …
prevent COVID-19 in adults. We aimed to estimate the impact of vaccination on the risk of …
Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study
R Grewal, SA Kitchen, L Nguyen, SA Buchan… - Bmj, 2022 - bmj.com
Objectives To estimate the marginal effectiveness of a fourth versus third dose and the
vaccine effectiveness of mRNA covid-19 vaccines BNT162b2 and mRNA-1273 against any …
vaccine effectiveness of mRNA covid-19 vaccines BNT162b2 and mRNA-1273 against any …
Effectiveness of COVID-19 vaccination against COVID-19 specific and all-cause mortality in older Australians: a population based study
Background Few studies have examined effectiveness of COVID-19 vaccines against
COVID-19 and all-cause mortality across different pandemic periods in 2022. Methods We …
COVID-19 and all-cause mortality across different pandemic periods in 2022. Methods We …
Vaccine-induced correlate of protection against fatal COVID-19 in older and frail adults during waves of neutralization-resistant variants of concern: an observational …
L Vikström, P Fjällström, YD Gwon… - The Lancet Regional …, 2023 - thelancet.com
Background To inform future preventive measures including repeated vaccinations, we have
searched for a clinically useful immune correlate of protection against fatal COVID-19 …
searched for a clinically useful immune correlate of protection against fatal COVID-19 …
Comparative risks of potential adverse events following COVID-19 mRNA vaccination among older US adults
Importance Head-to-head safety comparisons of the mRNA vaccines for SARS-CoV-2 are
needed for decision making; however, current evidence generalizes poorly to older adults …
needed for decision making; however, current evidence generalizes poorly to older adults …
[HTML][HTML] Length of hospital stay and risk of intensive care admission and in-hospital death among COVID-19 patients in Norway: a register-based cohort study …
R Whittaker, AB Kristofferson, BV Salamanca… - Clinical Microbiology …, 2022 - Elsevier
Objectives We estimated the length of stay (LoS) in hospital and the intensive care unit (ICU)
and risk of admission to ICU and in-hospital death among COVID-19 patients≥ 18 years in …
and risk of admission to ICU and in-hospital death among COVID-19 patients≥ 18 years in …